Iroxanadine (hydrobromide)
Iroxanadine hydrobromide (BRX 005) is a vasculoprotector. Iroxanadine is a p38 kinase and HSP protein dual activator. Iroxanadine hydrobromide has the potential for atherosclerosis and vascular diseases research[1].
Product Specifications
CAS Number
276690-62-1
Product Name Alternative
(-) -BRX 005 (hydrobromide) ; (-) -BRX 235 (hydrobromide)
UNSPSC
12352005
Target
HSP; p38 MAPK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; MAPK/ERK Pathway; Metabolic Enzyme/Protease
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/iroxanadine-hydrobromide.html
Smiles
C1(C2=CC=CN=C2)=NOCC(CN3CCCCC3)N1.Br
Molecular Formula
C14H21BrN4O
Molecular Weight
341.25
References & Citations
[1]Denes L, et al. Reverse regulation of endothelial cells and myointimal hyperplasia on cell proliferation by a heatshock protein-coinducer after hypoxia. Stroke. 2008 Mar;39 (3) :1022-4.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog